All treatments
Treatment
Docetaxel Accord 80 mg/4 ml concentrate for solution for infusion clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer
This study compares a new medicine called Sacituzumab Govitecan with standard treatments for advanced bladder cancer that has spread or can't be removed. Researchers want to see if the new medicine helps people live longer and feel better.
For: Locally Advanced or Metastatic Unresectable Urothelial CancerItaly · France · Sweden - Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients with Metastatic Non-Small Cell Lung Cancer (Morpheus-Lung)
This study is testing different combinations of treatments for advanced lung cancer. It's looking to see how well these new drug combinations work and if they are safe. The aim is to find better ways to treat non-small cell lung cancer that has spread.
For: Metastatic non-small cell lung cancer (NSCLC)France · Spain